New Jersey's Organ Procurement Organization on Brink of Federal Contract Loss Over Allegations of Egregious Actions and Potential Violations.
A federal investigation into New Jersey's organ procurement organization has uncovered "several egregious actions" and potential violations, including a whistleblower account of an organ being harvested from a living patient and allegations of a cover-up. The investigation led by lawmakers sent a scathing letter to the CEO of the New Jersey Organ and Tissue Sharing Network (NJTO), questioning whether the organization should retain its tax-exempt status.
The accusations against NJTO are part of a broader trend in federal oversight of the nation's 55 organ procurement organizations, which contract with the government to oversee organ donations and transplants. This is not an isolated incident; U.S. Health Secretary Robert F. Kennedy Jr. recently terminated a government contract with a Florida-based organization due to safety concerns.
The investigation's findings include allegations of potential Medicare fraud, lack of patient consent before harvesting organs, out-of-sequence organ transplants, and a culture of fear and retaliation within the organization. The letter cites whistleblowers who claimed NJTO staff contacted the CEO after an incident at Virtua Our Lady of Lourdes Hospital in Camden, New Jersey, where a patient "reanimated" after the donor organization began the process of recovering organs.
Furthermore, lawmakers allege that NJTO attempted to cover up this case by deleting both donation records and emails. This revelation has sent shockwaves through the organ transplant community, with one advocate labeling it as potentially criminal activity.
The investigation also raised concerns over NJTO's practices, including extracting pancreases only to meet a federal requirement for the number of donations. The organization claimed these were being recovered for research purposes but allegedly discarded 100 pancreases after hearing about federal on-site investigations at other organ procurement organizations.
NJTO has been accused of misleading families into believing a person was registered as an organ donor through the state's Motor Vehicle Commission, and the organization allegedly skipped patients on the waiting list for organs. The letter states that NJTO allocated 25% of all organs out of sequence, a rate higher than the national median.
As the investigation continues, lawmakers warn that the findings may inform legislative reforms aimed at closing loopholes in the system, which have led to "quid pro quo" relationships between hospitals and organ procurement organizations.
A federal investigation into New Jersey's organ procurement organization has uncovered "several egregious actions" and potential violations, including a whistleblower account of an organ being harvested from a living patient and allegations of a cover-up. The investigation led by lawmakers sent a scathing letter to the CEO of the New Jersey Organ and Tissue Sharing Network (NJTO), questioning whether the organization should retain its tax-exempt status.
The accusations against NJTO are part of a broader trend in federal oversight of the nation's 55 organ procurement organizations, which contract with the government to oversee organ donations and transplants. This is not an isolated incident; U.S. Health Secretary Robert F. Kennedy Jr. recently terminated a government contract with a Florida-based organization due to safety concerns.
The investigation's findings include allegations of potential Medicare fraud, lack of patient consent before harvesting organs, out-of-sequence organ transplants, and a culture of fear and retaliation within the organization. The letter cites whistleblowers who claimed NJTO staff contacted the CEO after an incident at Virtua Our Lady of Lourdes Hospital in Camden, New Jersey, where a patient "reanimated" after the donor organization began the process of recovering organs.
Furthermore, lawmakers allege that NJTO attempted to cover up this case by deleting both donation records and emails. This revelation has sent shockwaves through the organ transplant community, with one advocate labeling it as potentially criminal activity.
The investigation also raised concerns over NJTO's practices, including extracting pancreases only to meet a federal requirement for the number of donations. The organization claimed these were being recovered for research purposes but allegedly discarded 100 pancreases after hearing about federal on-site investigations at other organ procurement organizations.
NJTO has been accused of misleading families into believing a person was registered as an organ donor through the state's Motor Vehicle Commission, and the organization allegedly skipped patients on the waiting list for organs. The letter states that NJTO allocated 25% of all organs out of sequence, a rate higher than the national median.
As the investigation continues, lawmakers warn that the findings may inform legislative reforms aimed at closing loopholes in the system, which have led to "quid pro quo" relationships between hospitals and organ procurement organizations.